Exact Sciences
EXAS
#1153
Rank
A$28.65 B
Marketcap
A$150.14
Share price
0.00%
Change (1 day)
80.64%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.61. In 2024 the company made an earnings per share (EPS) of A-$7.97.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.547.13%
2024A-$7.97
2022A-$5.072.31%
2021A-$4.95-38.54%
2020A-$8.06692.96%
2019A-$1.02-50.69%
2018A-$2.0644%
2017A-$1.43-39.39%
2016A-$2.36-2.94%
2015A-$2.4337.1%
2014A-$1.7779.71%
2013A-$0.99-21.59%
2012A-$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$2.72-135.77%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$2.06-127.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.49-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$1.70-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$72.84 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA